Skip to main content
S&P 5007,637.76+1.14%DOW51,778.04+0.61%NASDAQ26,418.30+1.69%BTC$76,397.00+0.61%ETH$2,447.54+1.86%GOLD$4,380.60-0.43%OIL$101.09-0.80%
Smart Investors Daily
RP

NASDAQ · RPID

Rapid Micro Biosystems, Inc.

Healthcare · Medical - Devices

$1.11

Down-$0.02 (-1.80%)

Updated Sep 17, 2026, 9:48 PM

SID Score

2.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
164.95M
P/E ratio
-3.74
Dividend yield
0.00%
52-week range
$1.11 – $4.47
Volume
265K
Avg. volume
97.66K

Price performance

RPID price history

1M range · 20 trading sessions · Daily adjusted prices

RPID closed at $1.11 after 20 trading sessions, down 34.71% for the selected period.

Last close
$1.11
Period change
-34.71%
Period low
$1.11
Period high
$1.70
Daily close
View OHLC price history
RPID OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 16, 2026$1.16$1.18$1.11$1.11265K
Sep 15, 2026$1.19$1.19$1.13$1.15213.11K
Sep 14, 2026$1.23$1.23$1.155$1.17172.36K
Sep 11, 2026$1.22$1.26$1.20$1.23205.7K
Sep 10, 2026$1.20$1.2372$1.16$1.20385.17K
Sep 9, 2026$1.24$1.255$1.18$1.21409.34K
Sep 8, 2026$1.33$1.385$1.22$1.22312.44K
Sep 4, 2026$1.37$1.49$1.29$1.31378.83K
Sep 3, 2026$1.41$1.43$1.34$1.38107.26K
Sep 2, 2026$1.49$1.53$1.38$1.39204.98K
Sep 1, 2026$1.53$1.53$1.47$1.50167.55K
Aug 31, 2026$1.60$1.6132$1.48$1.52198.81K
Aug 28, 2026$1.62$1.63$1.55$1.5770.02K
Aug 27, 2026$1.67$1.68$1.61$1.61134.5K
Aug 26, 2026$1.67$1.7199$1.60$1.6791.09K
Aug 25, 2026$1.67$1.69$1.60$1.66186.64K
Aug 24, 2026$1.68$1.71$1.62$1.66200.53K
Aug 21, 2026$1.69$1.705$1.635$1.68122.66K
Aug 20, 2026$1.70$1.74$1.64$1.67323.18K
Aug 19, 2026$1.60$1.74$1.57$1.70297.24K

Latest RPID news

The latest Smart Investors Daily articles mentioning RPID.

Stock researchCompany · Overview

RPID research

Overview

Company profile and research snapshot.

Company profile

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$8.00
Implied upside
—
Analysts
—
RPID recent ratings
DateFirmRatingTarget
May 29, 2026KeybancOverweight—
May 22, 2026Lake StreetBuy—
Jul 28, 2025Lake StreetBuy—
Feb 12, 2025KeybancOverweight—
Mar 7, 2023Morgan StanleyEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 4, 2026

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced plans to participate in the following upcoming investor conferences: Thursday, September 10, 2026 - Lake Street’s 10th Annual Best Ideas Growth (BIG) Conference in New York, NY. The Comp

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By